Article
Silverback Therapeutics shuts down oncology program, plans to lay off 27% of workforce
Rating:
0.0
Views:
48
Likes:
1
Library:
1
Silverback Therapeutics will lay off 27% of its workforce and close its oncology program, the Seattle company announced Thursday in its fourth quarter earnings report.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value